New diabetes clinical trial: Study Targeting Myocardial Perfusion and Symptom Relief in Women with SGLT2 Inhibitors (STRONG)
Published on: September 18, 2024 at 11:00PM
Conditions: Angina Patients with Non-obstructive Coronary Artery Disease; Coronary Microvascular Disease; Coronary Microvascular Dysfunction (CMD)
Interventions: Drug: Dapagliflozin 10Mg Oral Tablet; Drug: Placebo
Sponsors: University of Virginia
Not yet recruiting
https://ift.tt/7lwdUVA
Conditions: Angina Patients with Non-obstructive Coronary Artery Disease; Coronary Microvascular Disease; Coronary Microvascular Dysfunction (CMD)
Interventions: Drug: Dapagliflozin 10Mg Oral Tablet; Drug: Placebo
Sponsors: University of Virginia
Not yet recruiting
https://ift.tt/7lwdUVA
Comments
Post a Comment